+ All Categories
Home > Documents > Patients Als

Patients Als

Date post: 14-Aug-2015
Category:
Upload: jescarra
View: 872 times
Download: 2 times
Share this document with a friend
Popular Tags:
48
1 1 Neuromuscular disorders: Respiratory assessment and ventilatory management. In patients with Amiotrophic Lateral Sclerosis Joan Escarrabill MD Master Plan of Respiratory Diseases (PDMAR) Institut d’Estudis de la Salut Barcelona [email protected] Stressa, April 4th 2009
Transcript

11

Neuromuscular disorders: Respiratory assessment and ventilatory management.

In patients with Amiotrophic Lateral Sclerosis

Joan Escarrabill MDMaster Plan of Respiratory Diseases (PDMAR)

Institut d’Estudis de la Salut

Barcelona

[email protected]

Stressa, April 4th 2009

2

ALS

Degeneration and death of motorneurons• Upper Motor Neuron

– within brain/spinal cord

• Lower Motor Neurons – leaves brain (stem)/spinal cord.

Incidence 1-2.5 / 100,000.

The life span of ALS patients is 3 to 5 years after they are diagnose.

3

ALS: Prognosis

Difficult to predict in an individual patient

3-4 yrs 50%

> 5 yrs 20%

> 10 yrs 10%

> 20 yrs Occasional

Life expectancy

4

ALS: 3 key words

Precocious Team

Package

5

ALS: 3 key words

Precocious Team

Package

6

Clinical presentation

Asymmetric Weakness (most common)

Onset single limb or bulbar

Local spread then regional spread Bulbar, cervical, thoracic, lumbosacral

Fasciculations

Acute respiratory failure

7

ALSClinical Signs and Symptoms

Clumsy hand Hoarse voice (dysarthria) Shoulder dysfunction Weak foot (foot drop) Difficulty walking (spastic gait) Exercise intolerance Fasciculation Respiratory insufficiency Cognitive impairment / emotional lability

8

ALS: Natural History

End of life

Diagnosis

Symptoms

Non Invasive Ventilation

9

ALS: Natural History

End of life

Diagnosis

Symptoms

Early indication of NIV

Natural History

10

ALS: Natural History

End of life

Diagnosis

Symptoms

Natural History

Palliative NIV

11

ALS: Natural History

End of life

Diagnosis

Symptoms

Natural History

Palliative NIV

Early indication of NIV

12

Chest 2007;127:2132-8

Early systematic respiratory evaluation is necessary to improve

the results of HMV in ALS

Survival in patients without bulbar involvement

Protocol

Pre-Protocol

13

Muscle strength vs Vital capacity

M. Estenne, 1991

14

Lung function

VC (lying, and sitting/standing)

20%

Sniff-Nasal Inspiratory force

Nocturnal pulsioxymetry

15

Eur Respir J 2008; 31: 93–98

Many patients with neuromuscular disease find the PImax manoeuvre difficult to perform

-70 cmH2O in males or ,-60 cmH2O in females is unlikely to be associated with inspiratory muscle weakness

Sniff-Nasal Inspiratory force (SNIP)

16

Am J Respir Crit Care Med 2005;171:269–274

Kaplan-Meier survival curves based on the SNIF categories

17

Lung & bulbar function:Signs and symptoms

Weight loss > 10%

Dysarthria

Dysphagia

Syalorrhea

Aspiration

Intolerance to supine position

Ineffective coughLung function

Bulbar function

18

ALS: 3 key words

Precocious Team

Package

19

Effective team It has a range of individuals who contribute in different

ways. Clear goals. Everyone understands the tasks they have to do. Coordinator There is a supportive, informal atmosphere. Comfortable with disagreement. A lot of discussion (Group members listen to each other) Feel free to criticise Learns from experience.

www.kent.ac.uk/careers/sk/teamwork.htm

20

The team produces more than the individual contributions of members.

21

Patient care team

Wagner. BMJ 2000;320:569-72.

R. Casas & P Romeu (1897)

22

Aiken L. NEJM 2003;348:164-6

Holistic vision

Better care related to coordination

Increasing role of non-physcian health professionals.

23

Mitsumoto H & Rabkin JG. JAMA. 2007;298:207-216

Care in multidisciplinary clinics is

associated with enhanced quality

of life by alleviating symptoms

and may extend survival

24

J Neurol Neurosurg Psychiatry 2006;77:948-50

Tertiary center

Neurology clinic

1080 days

775 days

The median survival from onsetwas 10 months longer

in ALS centers

4 yrs youngerPEG & NIV more oftenLess hospital admissions

25

www.has-sante.fr/

2003 17 Reference centers

CoodinationWorking groupsLocal organization

26

59%

41%

Ile de France Non ILD

Evalutaion of ALS reference centers

27

Survival of Irish ALS patients

One year mortality wasdecreased by 29.7%

Prognosis of bulbar onset patients was extended by 9.6 months

28

ALS patients who received their care at a multidisciplinary clinic had a better prognosis

Recruitment bias

ALS clinic treated a group of fitter ALS patients

General neurologistssaw all ALS patients

Living further from ALS clinicMore disabledIncreased ageBulbar onsetShorter duration of illness

Hutchinson M. J Neurol Neurosurg Psychiatry 2004;75:1208-12

29

Effect of referral bias

Sorenson EJ et al. Neurology 2007;68:600-602

132 subjectsTertiary center3 years.

Survival

p = 0.007

referral population

local

population

29 months 18 months

30

Zoccolella S et al. J Neurol 2007;254:1107-12

No improvements in survival: Low rate of interventions?

31

Home care organized through reference centers has many limitations

Complex organization, Distance, Response to emergencies

In most cases the reference center coordinates care but it can not assume direct care

32

Bias in the care of patients

Accessibility

Low rate of interventions

Distance

Referral Bias

33

ALS: Multidisciplinary Approach to Care

Neurologist Clinical/research nurse Dietician Speech/swallowing therapist Family/caregivers Psychologists General Practitioner Community nurse

Respiratory therapist Occupational therapist Social worker GI physician Support organizations Homehealth/hospice Pulmonologist Volunteer Helpers

Adapted from Leigh PN. J Neurol Neurosurg Psychiatry 2003;74(Suppl IV):iv32–iv47

34

Conclusions:

3 key words

Precocious Team

Package

35

ALS: Management

weakness fatigue nutrition dysphagia feeding tube dysarthria communication

spasticity cramps pain depression anxiety breathing end-of -life

36

Lancet Neurol 2006;5:140-7

37

Are NIV trials necessaries in ALS with non-bulbar impairement?

Servera E. Sancho S. Lancet Neurol 2006;5:140-7

Non-bulbar patients in control group

Stop studies according the results

Assessment efficacy of NIV

Pressure vs volume ventilators

Secretion management

It’s mandatory to evaluate therapy “package”

Ethical issues

Technical issues

38

“Therapy package” in ALS

Mobility Swallowing &

Speaking

Coping with changes

Breathingchanges

Symptoms

Caregiver

Adapted from www.alsa.org/

39

Coping with changes = Accessibility to the team Symptoms control Non invasive ventilation (tracheo?) Mechanical assisted cough Daily living activities aids Communication devices Percutaneous endoscopic gastrostomy Caregiver support End-of-life issues

“Therapy package” in ALS

40

Chest 2000;118:1390-6

41

Chest 2002;122:92-98

NIV Mechanical assisted cough Oximetry as feedback

Delay the need for tracheotomy

42

Chest 2004;125:1400-5

PCFMIC > 4 L/sMI-E not generate greater PCF than manually assisted coughing

PCFMIC < 2.7 L/s Dynamic collapse of the upper airway during the exsufflation

43

Lung function

Sancho J. Chest 2004;125:1400-5

44

Caregivers’ perception of the impact of ALS on the patients, The duration of ALS, The coping strategies employed, Satisfaction with the support services available

The QoL of caregivers is a complex interaction between:

Neurology 2006;66:1211–1217

45

www.patientslikeme.com/

46

Sweden 1965-2004

6642 patients

40 years

3 years

47

Mitsumoto H & Rabkin JG. JAMA. 2007;298:207-216

48

ALS: 3 key words

Precocious Team

Package

Especially in regard to lung function

Respiratory & Non-respiratory

Since the beginning of the disease


Recommended